Barinthus Biotherapeutics完成收购并退市ADS

TipRanks09/09 22:48

Barinthus Biotherapeutics推进法院批准的合并，并退出纳斯达克

TipRanks09/02 05:41

H.C. Wainwright维持Barinthus Biotherapeutics(BRNS.US)买入评级

H.C. Wainwright分析师Yi Chen维持$Barinthus Biotherapeutics(BRNS.US)$买入评级。根据TipRanks数据显示，该分析师近一年总胜率为45.0%，总平均回报率为1.7%。提示: TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做

富途资讯08/25 18:31

Barinthus Biotherapeutics: U.K. Court Hearing Scheduled for Sept. 1

Barinthus Biotherapeutics: U.K. Court Hearing Scheduled for Sept. 1

道琼斯08/25 07:04

Barinthus Biotherapeutics: Board Determines Share Exchange Ratio Will Be Sufficient for Nasdaq Price Requirements

Barinthus Biotherapeutics: Board Determines Share Exchange Ratio Will Be Sufficient for Nasdaq Price

道琼斯08/25 07:04

Barinthus Biotherapeutics Expects Combination With Clywedog Therapeutics to Become Effective Sept. 3

Barinthus Biotherapeutics Expects Combination With Clywedog Therapeutics to Become Effective Sept. 3

道琼斯08/25 07:02